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Discussion
Dr Neil Christie (Pittsburgh, Pa). I have no conflicts to disclose.
Earlier studies in thoracoscopic lobectomy focused on feasibility
and technique. That having been established, there is now an inter-
est to determine if it is superior to the open thoracotomy technique
and, as such, should become the standard of care. This paper has
demonstrated a significant decrease in perioperative complications
and a shortened length of stay with the thoracoscopic approach to
lobectomy.
I would now like to ask a few questions. First, all thoracoscopic
lobectomy series have a subset of patients in whom conversion to
thoracotomy is required, occasionally due to intraoperative compli-
cations such as bleeding. In your analysis, it would seem that these
conversion cases are not included in the thoracoscopic group, po-
tentially biasing your study in favor of thoracoscopy. Could you
please comment on this?
Dr Subroto Paul (New York, NY). Excellent question. There
were patients who were excluded, 17 patients in total, who had
VATS lobectomy as well as thoracotomy listed as a procedure per-
formed. Looking at the STS database, it is difficult to ascertain
which patients were conversion cases and trying to keep them as
an intent-to-treat analysis. So we did exclude those patients, and
these are a pure group of patients who just had completed
a VATS lobectomy versus an open thoracotomy lobectomy. It
does introduce bias and, hence, why this trial is not the equivalent
of a randomized trial with an intention-to-treat analysis.The Journal of Thoracic and CaDr Christie. My second question is, some authors recommend
thoracoscopic lobectomy only for stage I node-negative cancers
due to the potential of increased difficulty of resection with en-
larged lymph nodes. Your study included patients with stage II
and stage III cancer. Were you able to do a subset analysis of out-
comes with clinical stage II and stage III lung cancers, and would
you recommend the thoracoscopic approach as being optimal in
these patients?
Dr Paul. A separate analysis was performed using clinical stage
as a preoperative variable and including only clinical stage I and
stage II patients, and the outcomes were very similar, with the
same rates of lower atrial fibrillation, reintubation.
In terms of the second question, could you elaborate a little bit
more?
Dr Christie. In that subset of patients who had more advanced
disease and clinical nodal disease, do you think the complication
rates would still be lower than that seen with thoracotomy?
Dr Paul. It seems from our data that if you had a VATS lobec-
tomy, even for a higher-stage disease, your complication rates are
lower, and that is supported by several other single-institution stud-
ies. Further analysis of the data would be needed just to look at that
subset.
Dr Christie. My final question is, acknowledging the potential
selection bias in your study, would you and your colleagues recom-
mend that a prospective randomized study be undertaken of thora-
coscopic lobectomy versus open thoracotomy?
Dr Paul. Well, the gold standard would be to have a randomized
trial, but the number of patients that would need to be recruited
would be in excess of probably 1000 in each arm to show some
of these complications, so it would be difficult to perform and con-
duct. I don’t think it will ever be done, but it probably should be
done.
Thank you.
Dr David Cooke (Sacramento, Calif). Very good presentation,
Subroto.
I have a couple questions. One, did you match the thoracoscopic
group and the open lobectomy group with patients having medias-
tinal lymph node sampling or dissections? The assumption is that
most of these patients probably did have mediastinal lymph node
sampling or dissection, but from previous studies, it’s not 100%.
In fact, there is a good percentage of patients who do not have sam-
pling or dissection. That might affect possibly the length of chest
tube duration, among other outcomes.
Dr Paul. Excellent question. We are kind of limited by the da-
tabase, which does not include dissection versus sampling within
the study, so that is not included as part of the matching process,
and that may have affected the results. I think that is one of the ques-
tions that we’re trying to get at through indirect means through the
STS database.
DrCooke. The second question is, did you look at differences in
terms of intensive care unit admissions and hospital readmissions
between the 2 groups?
Dr Paul. That is also another excellent question. Those are pa-
rameters that are not included in the STS database, so we could not
look at them.
Dr Raja Flores (New York, NY). Nice study, Subroto. I have
a word of caution, though. I think when one looks at conver-
sion, it seems as if the ascertainment of the data for the STSrdiovascular Surgery c Volume 139, Number 2 373
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Sdatabase may be a bit skewed with regard to patients who were
converted. If you look at the data, you had 17 patients who had
both thoracoscopy and thoracotomy out of 1300. Potentially
those are conversions. It’s not known for sure. If those are con-
versions, that number is very small. If you look at the prospec-
tive study, the CALGB trial, of surgeons who are technically
very facile in doing VATS lobectomy, their conversion rate
was 14%. So for the database, I think that’s low. And whenever
you have a group of patients who are converted, the proper374 The Journal of Thoracic and Cardiovascular Surganalysis is not to exclude them but to include them in the
VATS lobectomy group so as to minimize any bias in favor
of VATS. Overall, I think it was an excellent study based on
the data available, but I think there are some major limitations
with the ascertainment of the data for the database that limit
the conclusions of this study.
Dr Paul. I agree with your point. There are some things that
were limited by the database in terms of what information we can
get out of it.ery c February 2010
